This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This UBASH3A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 313-340 amino acids from the Central region of human UBASH3A.
UBASH3A
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
UBASH3A
(Ubiquitin Associated and SH3 Domain Containing, A (UBASH3A))
UBASH3A antikoerper, CLIP4 antikoerper, STS-2 antikoerper, TULA antikoerper, TULA-1 antikoerper, 5830413C03Rik antikoerper, C330001M22 antikoerper, Sts-2 antikoerper, ubiquitin associated and SH3 domain containing A antikoerper, ubiquitin associated and SH3 domain containing, A antikoerper, UBASH3A antikoerper, Ubash3a antikoerper
Hintergrund
UBASH3A interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors, EGFR and PDGFRB, on the cell surface.